Paladin Capital Group invests in 10X Genomics, Inc.

On November 1, 2011, Paladin Capital Group invested in 10X Genomics, Inc., a medical products company in California, United States.

Deal at a glance

AnnouncedNovember 1, 2011 TypeVenture Target10X Genomics, Inc. Buyer Paladin Capital Group SectorMedical Products LocationCalifornia, United States ValueNot disclosed

Target company

10X Genomics, Inc.

California, United States

Medical Productssector

-founded

Activestatus

View the company profile →

Buyer

Paladin Capital Group

Private equity firm · 57 deals on record

1st transaction in medical products
40th transaction in United States

57deals, all time

1in this sector

2018latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Seraplex, Inc.Same sector and country · Oct 2026

Aloe Care Health, Inc.Same sector and country · Apr 2026

Hologic, Inc.Same sector and country · Apr 2026

Questions about this deal

Who acquired 10X Genomics, Inc.?Paladin Capital Group invested in 10X Genomics, Inc. on November 1, 2011.

What type of deal was it?It was a venture in the medical products sector in 2011.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).